title: Tailored strategies for radiation therapy in classical Hodgkin's lymphoma.
abstract: Radiotherapeutic advances have contributed to the evolution of Hodgkin's lymphoma (HL) treatment paradigms. A reduction in radiation therapy (RT) field size and dose has the potential to significantly impact the therapeutic ratio by diminishing late toxicities while maintaining curability. Substantial progress in risk stratification has contributed to the development of tailored RT strategies which address both field design as well as dose. Technologic improvements have also enhanced the ability to adapt the RT technique to the individual patient. The refinement of the RT approach and its incorporation into current combined modality strategies in adult classical HL is the subject of ongoing investigation and is critically reviewed.
authors.affiliation: Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA. stereza1@jhmi.edu
authors.forename: Stephanie A
authors.initials: SA
authors.lastname: Terezakis
authors.forename: Yvette L
authors.initials: YL
authors.lastname: Kasamon
mesh_terms: D003131:Combined Modality Therapy; D006689:Hodgkin Disease / Q000532:radiotherapy*; D006801:Humans; D011829:Radiation Dosage